Modulation of cyclooxygenase-2 expression by APC in HT-29 human colorectal carcinoma cells.
作者信息
Hsi Linda C, Angerman-Stewart Julie, Eling Thomas E
机构信息
National Institute of Environmental Health Sciences, Eicosanoid Biochemistry Section, Laboratory of Molecular Carcinogenesis, Research Triangle Park, NC 27709, USA.
出版信息
Adv Exp Med Biol. 2002;507:127-31. doi: 10.1007/978-1-4615-0193-0_21.
PMID:12664576
Abstract
摘要
相似文献
1
Modulation of cyclooxygenase-2 expression by APC in HT-29 human colorectal carcinoma cells.
Adv Exp Med Biol. 2002;507:127-31. doi: 10.1007/978-1-4615-0193-0_21.
2
3
Introduction of full-length APC modulates cyclooxygenase-2 expression in HT-29 human colorectal carcinoma cells at the translational level.
Carcinogenesis. 1999 Nov;20(11):2045-9. doi: 10.1093/carcin/20.11.2045.
4
[Rationale and prospects for the use of cyclooxygenase-2 (COX-2) inhibitors in colorectal cancer].
Gastroenterol Clin Biol. 2001 Nov;25(11):967-78.
5
Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2).
Cell. 1996 Nov 29;87(5):803-9. doi: 10.1016/s0092-8674(00)81988-1.
6
The inducible prostaglandin biosynthetic enzyme, cyclooxygenase 2, is not mutated in patients with attenuated adenomatous polyposis coli.
Cancer Res. 1998 Nov 1;58(21):4909-12.
7
Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasms.
Mol Carcinog. 1999 Mar;24(3):177-87.
8
Growth regulation of Gardner's syndrome colorectal cancer cells by NSAIDs.
Adv Exp Med Biol. 1997;407:433-41. doi: 10.1007/978-1-4899-1813-0_64.
9
[The transgenic mouse model of familial polyposis coli].
Z Gastroenterol. 1997 Nov;35(11):1035-7.
10
[Colorectal cancer and inhibition of cyclooxygenase-2].
Dtsch Med Wochenschr. 2002 Jun 7;127(23):1256-8. doi: 10.1055/s-2002-32104.
Zotero 插件